Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempus AI

43.81
-5.2900-10.77%
Volume:8.37M
Turnover:377.21M
Market Cap:7.54B
PE:-7.04
High:48.49
Open:48.06
Low:43.62
Close:49.10
Loading ...

Tempus Announces the National Launch of FDA-Approved xT CDx Test

Business Wire
·
15 Jan

Tempus AI (TEM) Launches AI-Powered Whole-Genome Sequencing Test to Transform Precision Medicine

Insider Monkey
·
15 Jan

Stock Track | Tempus AI Soars 5.07% as New GenAI Capabilities and ARK Investment Boost Confidence

Stock Track
·
14 Jan

BRIEF-Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care

Reuters
·
14 Jan

Tempus One Introduces New Genai Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care

THOMSON REUTERS
·
14 Jan

TEM Stock Declines Following Preliminary Q4 Sales Miss

Zacks
·
14 Jan

Tempus AI Price Target Maintained With a $56.00/Share by Needham

Dow Jones
·
14 Jan

Cathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-Off

GuruFocus
·
14 Jan

Cathie Wood’s ARKG Loads Up on Tempus AI (NASDAQ:TEM) as Stock Plunges on Revenue Miss

TIPRANKS
·
14 Jan

Here’s Why Tempus AI, Inc (TEM) Is Among Monday’s Top Losers

Insider Monkey
·
14 Jan

Cathie Wood’s ARK Investment bought 379K shares of Tempus AI today

TIPRANKS
·
14 Jan

Stock Track | Tempus AI Soars 6.65% on xH Whole-Genome Sequencing Announcement Despite Growth Concerns

Stock Track
·
14 Jan

Sector Update: Tech Stocks Decline Late Afternoon

MT Newswires Live
·
14 Jan

Tempus AI Reports Preliminary 2024 Revenue of $693 Million, Shares Fall Over 14%

GuruFocus.com
·
14 Jan

Tempus AI: Balancing Promising Growth with Current Performance Shortfalls

TIPRANKS
·
14 Jan

Tempus AI Preliminary Q4, 2024 Revenue Misses Estimates; Shares Fall

MT Newswires Live
·
14 Jan